BioSpace News Archive

Drug Development

RXi Pharmaceuticals Announces Positive NeuVaxTM (E75) Phase 2 Efficacy Results After 36 Months of Follow-Up

June 6, 2011
·
1 min read
BioMidwest

Myriad Genetics, Inc.'s PROLARIS(R) Test Shown to Significantly Predict Prostate Cancer Outcome From Needle Biopsy Tissue

June 6, 2011
·
1 min read
Drug Development

Vical Incorporated Presents Positive Correlation Between Response and Survival at American Society of Clinical Oncology for Completed Allovectin(R) Melanoma Trials

June 6, 2011
·
1 min read
Genetown

BG Medicine to Present at the Jefferies and Co. 2011 Global Healthcare Conference

June 6, 2011
·
1 min read
Pharm Country

Keryx Biopharmaceuticals to Present at Jefferies and Co. 2011 Global Healthcare Conference

June 6, 2011
·
1 min read
Biotech Beach

Amylin Pharmaceuticals, Inc. Release: Study Finds Treatment with Metreleptin Improved Diabetes and Lipid Control in Patients with Partial Lipodystrophy

June 6, 2011
·
7 min read
Genetown

Charles River Laboratories (Massachusetts) to Present at June Investor Conferences

June 6, 2011
·
1 min read
Business

Can-Fite BioPharma Signed an Agreement to Spin off Its Ophthalmology Activities to a US Based Public Company

June 6, 2011
·
2 min read
Drug Development

OncoGenex Pharmaceuticals Inc. Release: Data from Pre-Clinical Studies Presented at the 2011 American Society of Clinical Oncology Annual Meeting Show Potential Combinability of Custirsen with MDV3100 and Hsp90 Inhibitors to Enhance Anti-Tumor Activity in

June 6, 2011
·
5 min read
Drug Development

United Therapeutics Corporation’s FREEDOM-M Phase 3 Trial of Oral Treprostinil in Pulmonary Arterial Hypertension Meets Primary Endpoint

June 6, 2011
·
12 min read